2013 annual financial data
ImmuCell 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was 18.29%.
Operating income was -19,552 USD and net income was 117,395 USD.
Operating cash flow was 1,098,660 USD.
Get free ImmuCell email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,007,176 USD
- Operating income
- -19,552 USD
- Net income
- 117,395 USD
- Operating cash flow
- 1,098,660 USD